Biopharma Business

Tag "Cinryze"

Shire’s HAE drug Cinryze secures label extension in Europe

Shire has secured label expansion approval from the European Commission for its hereditary angioedema therapy Cinryze. The European Commission (EC) has approved the label extension application, granting three new indications

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here